Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector.

AUTOR(ES)

Bernards, R

RESUMO

We have constructed a vaccinia virus recombinant that expresses the extracellular domain of the rat neu oncogene-encoded protein, a 185-kDa transmembrane glycoprotein termed p185. Strain NFS mice immunized with this recombinant virus developed a strong antibody response against the neu oncogene product and were fully protected against subsequent tumor challenge with neu-transformed NIH 3T3 cells. No tumor immunoprotection was found when recombinant virus-immunized mice were challenged with Ha-ras-transformed NIH 3T3 cells. These data indicate that immunization with a single oncogene-encoded antigen can fully and specifically protect animals against tumor cells bearing this antigen.

Documentos Relacionados

• Protection of mice against tumor growth by immunization with an oncogene-encoded growth factor.
• Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen.
• Isolation of antibodies for phosphotyrosine by immunization with a v-abl oncogene-encoded protein.
• Differential modulation of plasminogen activator gene expression by oncogene-encoded protein tyrosine kinases.
• Monoclonal antibodies to individual tyrosine-phosphorylated protein substrates of oncogene-encoded tyrosine kinases.